Floatz logo

TERIPARATIDE

Hypoparathyroidism

National Institutes of Health Clinical Center (CC)protein_peptidePhase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hypoparathyroidism cohort.

Asset / SponsorPhaseRating
SODIUM CITRATE
National Center for Research Resources (NCRR)
D
CALCAREA GLUCONICA
National Center for Research Resources (NCRR)
D

Same molecule, other indications

TERIPARATIDE is also rated in:

autoimmune polyendocrine syndrome type 1Dormant
CCC
Indicative ·
55 / 100
View asset →
autosomal dominant hypocalcemia 1Dormant
CCC
Indicative ·
55 / 100
View asset →
Bartter syndrome with hypocalcemiaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →